03/11/22
Overview
The Infinium LCG_PGx workflow for the new Global Diversity Array + Enhanced PGx Content (GDA + PGx) includes a new targeted gene amplification (TGA) step. TGA is a PCR amplification for specific pharmacogenomic (PGx) content, which allows for pseudogene disambiguation. The PGx TGA is combined with the Infinium whole genome amplification (WGA) before the Fragment step. The combined sample is processed through the standard LCG Infinium workflow from Fragment on.
The TGA reagents contain a probe that generates a sample-independent TGA positive control fragment. This control fragment binds to the TGA Control Probe on the array when the PGx TGA and WGA are properly executed, recombined, and processed in the Infinium assay. The TGA Control Probe should have a positive signal, observed as Norm R on the Y axis of the SNP graph in GenomeStudio 2.0. The performance expectation for the TGA Control Probe (TGA_Ctrl_5716) is R > 1.
Table 1: GDA+ PGx Product specifications
Data Performance | Product Specification |
---|---|
Call Rate | > 99.0% Avg |
Log R Deviation | <0.3 |
Evaluate performance of the PGx TGA Control Probe
*Download product files from the Infinium Global Diversity Array with Enhanced PGx Product Files page.
For additional questions regarding sample and probe performance, contact Illumina Technical Support at techsupport@illumina.com